Vanguard Group Inc 10x Genomics, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 13,274,332 shares of TXG stock, worth $211 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,274,332
Previous 12,440,060 6.71%
Holding current value
$211 Million
Previous $144 Million 7.72%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$11.34 - $14.64 $9.46 Million - $12.2 Million
834,272 Added 6.71%
13,274,332 $155 Million
Q2 2025

Aug 11, 2025
BUY
$7.14 - $11.73 $9.44 Million - $15.5 Million
1,321,974 Added 11.89%
12,440,060 $144 Million
Q1 2025

May 09, 2025
BUY
$8.73 - $16.31 $1.61 Million - $3.01 Million
184,537 Added 1.69%
11,118,086 $97.1 Million
Q4 2024

Feb 11, 2025
SELL
$13.18 - $21.31 $519,041 - $839,209
-39,381 Reduced 0.36%
10,933,549 $157 Million
Q3 2024

Nov 13, 2024
BUY
$15.71 - $23.49 $12.3 Million - $18.4 Million
783,673 Added 7.69%
10,972,930 $248 Million
Q2 2024

Aug 13, 2024
BUY
$19.45 - $37.37 $21.2 Million - $40.6 Million
1,087,721 Added 11.95%
10,189,257 $198 Million
Q1 2024

May 10, 2024
BUY
$36.08 - $54.3 $3.25 Million - $4.9 Million
90,204 Added 1.0%
9,101,536 $342 Million
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $3.7 Million - $6.2 Million
107,815 Added 1.21%
9,011,332 $504 Million
Q3 2023

Nov 14, 2023
BUY
$40.86 - $62.98 $14.5 Million - $22.4 Million
354,921 Added 4.15%
8,903,517 $367 Million
Q2 2023

Aug 14, 2023
SELL
$50.96 - $58.72 $12 Million - $13.8 Million
-235,025 Reduced 2.68%
8,548,596 $477 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $12.8 Million - $20.3 Million
363,610 Added 4.32%
8,783,621 $490 Million
Q4 2022

Feb 10, 2023
BUY
$24.4 - $41.3 $3.55 Million - $6.02 Million
145,652 Added 1.76%
8,420,011 $307 Million
Q3 2022

Nov 14, 2022
BUY
$28.48 - $52.59 $12.7 Million - $23.5 Million
446,601 Added 5.71%
8,274,359 $236 Million
Q2 2022

Aug 12, 2022
BUY
$36.95 - $82.41 $3.52 Million - $7.85 Million
95,235 Added 1.23%
7,827,758 $354 Million
Q1 2022

May 13, 2022
BUY
$55.7 - $145.79 $9.94 Million - $26 Million
178,481 Added 2.36%
7,732,523 $588 Million
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $6.75 Million - $9.13 Million
-50,002 Reduced 0.66%
7,554,042 $1.13 Billion
Q3 2021

Nov 12, 2021
BUY
$145.58 - $192.14 $76.4 Million - $101 Million
524,475 Added 7.41%
7,604,044 $1.11 Billion
Q2 2021

Aug 13, 2021
BUY
$134.22 - $202.37 $950 Million - $1.43 Billion
7,079,569 New
7,079,569 $1.39 Billion

Others Institutions Holding TXG

# of Institutions
353
Shares Held
118M
Call Options Held
266K
Put Options Held
191K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email